General Counsel and Secretary · BALCHEM CORP (BCPC)

Mark Stach

A named executive officer of BALCHEM in every fiscal year CompBrief holds from FY2017 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$981,066

Salary $350,850Stock awards $258,229

FY2020: $852,406

5th of 7 named executive officers at Balchem by FY2021 total.

7 named officers on file for BALCHEM, FY2021

Mark Stach’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • BCPC’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BALCHEM’s whole pay program stands against its peers

  • BALCHEM’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BCPC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2022 (DEF 14A).

Free

Get Mark Stach’s full pay file as a PDF — free

More than this page: up to 10 years of Mark’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Mark Stach compensation by year

BALCHEM Summary Compensation Table · all 5 fiscal years held
In US dollars, as BALCHEM reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021
Salary$222,998$257,967$291,205$330,889$350,850
Bonus$38,900$0$0$0$0
Stock awards$0$188,147$365,232$227,831$258,229
Option awards$51,964$63,308$65,658$76,065$86,086
Non-equity incentive$0$122,567$107,299$198,021$265,451
Pension and deferred compensation—$-2,046$24,533$0$0
All other$0$0$19,600$19,600$20,450
Total$313,862$629,943$873,527$852,406$981,066

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BALCHEM CORP DEF 14A filed April 29, 2022, accession 0001140361-22-016931, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BALCHEM CORP filed document, accession 0001140361-22-016931. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.

$314K
$630K
$874K
$852K
$981K
FY17
FY18
FY19
FY20
FY21
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU5,020$846,372—
RSU4,140$698,004—
Option1,440—$84.09
Option2,640—$111.13
Option2,600—$119.13

Per the Outstanding Equity Awards at Fiscal Year-End table in BALCHEM CORP's FY2021 proxy; value at the fiscal year-end close, as the company printed it.

BALCHEM’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Ted HarrisChairman, President and Chief Executive Officer$5,761,673
Martin BengtssonChief Financial Officer and Treasurer$1,688,893
Martin ReidChief Supply Chain Officer$1,432,728
Jim HydeFormer Senior Vice President and General Manager, Human Health and Nutrition$1,240,324
Mark Stach · this pageGeneral Counsel and Secretary$981,066
William BackusChief Accounting Officer$960,419
Jonathan GriffinSenior Vice President and General Manager, Animal Nutrition and Health$868,791

The full BALCHEM compensation record

free company brief

This page is one person within BALCHEM's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the BALCHEM proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BALCHEM's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Mark Stach's compensation dossier · One-time report. No refunds.